Psychosocial Challenges of Elderly Patients Coping With Cancer

Alon, Shirly

doi:10.1097/mph.0b013e318230ddcb

Cited by 5 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The success of any screening is related to the inclusion of unmet needs, the acceptability of the screening, and the acceptance and availability of psychosocial caregivers. 45,46 The aim of our study was to demonstrate the importance of an understanding of the difficulties, challenges and developmental tasks that patients with renal cancer face as the specific psychosocial issues of these patients have not been well studied. Patients with renal cancer are typically elderly and psychosocial distress in elderly patients is often underdiagnosed and undertreated.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Analysis of psychosocial stress factors in patients with renal cancer

Draeger

Sievert

Hakenberg

2018

Therapeutic Advances in Urology

View full text Add to dashboard Cite

There is a significant number of patients with renal cancer with increased psychological distress and a consecutive need for psychosocial care. This is underreported and largely unrecognized by patients as well as physicians and nurses. Easy-to-use assessment tools can be very helpful in identifying patients in need and this information can be used to implement psychological support and thus improve patient care.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The success of any screening is related to the inclusion of unmet needs, the acceptability of the screening, and the acceptance and availability of psychosocial caregivers. 45,46…”

Section: Discussionmentioning

confidence: 99%

Analysis of psychosocial stress factors in patients with renal cancer

Draeger

Sievert

Hakenberg

2018

Therapeutic Advances in Urology

View full text Add to dashboard Cite

show abstract

“…Moreover, they are often excluded or underrepresented in clinical trials, and among those who do enroll, detailed data regarding comorbid conditions and psychological factors are not routinely captured [1,2,3,4,5,6]. Beside their underrepresentation, studies which include older patients are likely to have selection bias ‘only fit elderly patients were included' [4,7].…”

Section: Introductionmentioning

confidence: 99%

Chemotherapy Regimen in Nonagenarian Cancer Patients: A Bi-Institutional Experience

Rivoirard¹,

Chargari

Kullab³

et al. 2015

Chemotherapy

View full text Add to dashboard Cite

Background: The elderly population in Western countries is growing and constitutes a public health issue. Concomitantly, age-related diseases such as cancer increase. There are few data on the efficacy, tolerability and toxicity of specific anticancer therapy in the very elderly patients; therefore, their management is not standardized. Methods: In this bi-institutional study, we reviewed medical records of patients who received or continued specific anticancer therapy beyond the age of 90 years. Geriatric assessment was not reported for our patients. Twelve patients were enrolled. Their general health condition was good, and half of them were living in elderly institutions. Ten patients had a solid tumor and 2 were treated for hematological malignancies. Most were diagnosed with a locally advanced or metastatic disease, and the goal of treatment was curative for only 1 patient. Six patients received chemotherapy as first-line treatment, 4 patients received targeted therapy and 2 received concomitant chemoradiation. Four patients received a second-line treatment. Results: Despite a significant reduction in treatment posology in half of the patients, 8 acute grade 3/4 toxicities were reported and 2 patients died of treatment-related septic shock. Median duration of first-line treatment was 3.2 months, and progression-free survival ranged from 18 to 311 days. Overall survival ranged from 18 days to 11 years. Conclusion: Aging is a heterogeneous process, and management of elderly patients is a multidisciplinary approach. Geriatric assessment helps to identify older patients with a higher risk of morbidity/mortality and allows to assess the risks and benefits of specific anticancer therapy. The choice of treatment should be based primarily on the expected symptomatic benefit, and treatment should not compromise the quality of life.

show abstract

The increasing prevalence of cancer in the elderly: An investigation of epidemiological trends

Prathap,

Kirubha,

Rajan

et al. 2024

Aging Medicine

View full text Add to dashboard Cite

Cancer poses a significant health threat to the elderly, accounting for a substantial proportion of cancer patients aged 65 and above. As life expectancy continues to rise and the population ages, the incidence of cancer in the elderly is expected to increase further. Age is a major risk factor for the majority of common cancers, with the incidence and prevalence rising as individuals grow older. Factors such as chemoprevention and environmental carcinogen elimination may influence the process of carcinogenesis. Studies reveal that the incidence and mortality rates of various cancers in the elderly and extremely old individuals are on the rise worldwide, with most types peaking around the age of 75 to 90, followed by a sharp decline. Birth cohort and period effects also play a complex role in the connection between aging and cancer risk. Clinical trials often exclude older individuals, limiting our understanding of cancer treatments' effects on this particular age group. More research is needed to focus on the unique requirements of older adults with cancer.

show abstract

Psychosocial Challenges of Elderly Patients Coping With Cancer

Cited by 5 publications

References 13 publications

Analysis of psychosocial stress factors in patients with renal cancer

Analysis of psychosocial stress factors in patients with renal cancer

Chemotherapy Regimen in Nonagenarian Cancer Patients: A Bi-Institutional Experience

The increasing prevalence of cancer in the elderly: An investigation of epidemiological trends

Contact Info

Product

Resources

About